Skip to content

NEI Research News

Thanks to the work of NEI scientists and grantees, we’re constantly learning new information about the causes and treatment of vision disorders. Get the latest updates about their work — along with other news about NEI.

Source
851 items
2 young boys hold balls and smile at the camera

NIH study provides clarity on supplements for protection against blinding eye disease

Adding omega-3 fatty acids did not improve a combination of nutritional supplements commonly recommended for treating age-related macular degeneration (AMD), a major cause of vision loss among older Americans.
National Eye Institute logo.

Targeting cholesterol buildup in eye may slow age-related vision loss

Targeting cholesterol metabolism in the eye might help prevent a severe form of age-related macular degeneration (AMD), one of the most common causes of blindness in older Americans.
National Eye Institute logo.

Seven genetic risk factors found to be associated with common eye disorder

An international group of researchers has discovered seven new regions of the human genome—called loci-that are associated with increased risk of age-related macular degeneration (AMD), a leading cause of blindness.
National Eye Institute logo.

NEI Grantee Edward Boyden Honored with Prestigious Million Euro Brain Prize

Edward S. Boyden, Ph.D., a neuroscientist and NEI grantee at the Massachusetts Institute of Technology in Boston, has been honored with a 2013 Brain Prize.
NIH National Eye Institute logo

NEI-Funded Device for People with RP Gets FDA Approval

On February 14, 2013, the U.S. Food and Drug Administration approved the Argus II Retinal Prosthesis System, the first implanted device to treat adult patients with advanced retinitis pigmentosa (RP).
National Eye Institute logo.

New Findings Suggest Need for Combined Strategy in Treatment of Rare Form of Blindness

In 2008, a team of scientists funded by the National Eye Institute (NEI), a part of the National Institutes of Health, reported major progress in the treatment of an inherited form of progressive blindness using gene therapy.
Two boys smile at camera. Dark spot in center of image represents vision loss from AMD.

NIH study suggests immune system could play a central role in AMD

Changes in how genes in the immune system function may result in age-related macular degeneration (AMD), the leading cause of visual impairment in older adults, based on preliminary research conducted by National Institutes of Health (NIH) investigators.
National Eye Institute logo.

Retinal Device Restores Sight in Mice

Researchers have developed a new prosthetic technique that can restore vision to blind mice. The approach could potentially be further developed to improve sight in blind people.
National Eye Institute logo.

United States and United Kingdom Collaborate on Ocular Immunology

The NEI, part of the National Institutes of Health (NIH), has become the first U.S. government agency to develop a formal collaborative research and training agreement with the United Kingdom’s National Health Service (NHS).
National Eye Institute logo.

Avastin and Lucentis are equivalent in treating age-related macular degeneration

At two years, Avastin (bevacizumab) and Lucentis (ranibizumab injection), two widely used drugs to treat age-related macular degeneration (AMD).

Want more news from NEI?

Subscribe to our news feed to stay up to date on vision and eye health research!

Success! Link copied to clipboard.

Copy to clipboard failed.

You can also browse older stories in our news archive

NEI Press Office

We can connect media professionals with the latest vision research info. Get in touch!


Phone: 301-496-5248